ProShare Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.35M Sell
15,951
-2,042
-11% -$513K 0.01% 626
2025
Q4
$5.11M Buy
17,993
+5,517
+44% +$1.72M 0.01% 553
2025
Q3
$3.85M Sell
12,476
-3,181
-20% -$997K 0.01% 600
2025
Q2
$4.92M Buy
15,657
+1,055
+7% +$304K 0.01% 549
2025
Q1
$3.83M Buy
14,602
+3,988
+38% +$1.08M 0.01% 567
2024
Q4
$2.77M Buy
10,614
+1,159
+12% +$292K 0.01% 633
2024
Q3
$2.2M Sell
9,455
-3,216
-25% -$660K 0.01% 662
2024
Q2
$2.56M Sell
12,671
-372
-3% -$67K 0.01% 627
2024
Q1
$2.24M Sell
13,043
-250
-2% -$46.6K 0.01% 650
2023
Q4
$2.88M Sell
13,293
-1,004
-7% -$172K 0.01% 594
2023
Q3
$2.28M Sell
14,297
-813
-5% -$182K 0.01% 628
2023
Q2
$4.36M Buy
15,110
+4,358
+41% +$1.32M 0.01% 520
2023
Q1
$3.43M Buy
10,752
+9,699
+921% +$2.87M 0.01% 571
2022
Q4
$310K Sell
1,053
-52
-5% -$14.3K ﹤0.01% 1224
2022
Q3
$253K Sell
1,105
-32
-3% -$8.02K ﹤0.01% 1246
2022
Q2
$248K Sell
1,137
-440
-28% -$100K ﹤0.01% 1328
2022
Q1
$420K Sell
1,577
-154
-9% -$37.8K ﹤0.01% 1402
2021
Q4
$461K Buy
1,731
+97
+6% +$28.1K ﹤0.01% 1513
2021
Q3
$464K Sell
1,634
-761
-32% -$217K ﹤0.01% 1248
2021
Q2
$657K Buy
2,395
+1,153
+93% +$313K ﹤0.01% 1328
2021
Q1
$324K Buy
1,242
+58
+5% +$15.5K ﹤0.01% 1755
2020
Q4
$303K Buy
1,184
+48
+4% +$11.9K ﹤0.01% 1604
2020
Q3
$269K Buy
1,136
+79
+7% +$16.6K ﹤0.01% 1248
2020
Q2
$205K Buy
+1,057
New +$202K ﹤0.01% 1449
2020
Q1
Sell
-1,478
Closed -$253K 1478
2019
Q4
$253K Buy
1,478
+60
+4% +$10K ﹤0.01% 1444
2019
Q3
$234K Buy
+1,418
New +$199K ﹤0.01% 1352
2019
Q2
Sell
-2,374
Closed -$226K 1647
2019
Q1
$226K Buy
+2,374
New +$203K ﹤0.01% 1397
2018
Q4
Sell
-2,082
Closed -$221K 1668
2018
Q3
$221K Buy
+2,082
New +$195K ﹤0.01% 1542
2018
Q2
Sell
-7,433
Closed -$644K 1803
2018
Q1
$644K Sell
7,433
-1,199
-14% -$93.1K ﹤0.01% 998
2017
Q4
$596K Buy
8,632
+4,636
+116% +$304K ﹤0.01% 1047
2017
Q3
$220K Sell
3,996
-1,142
-22% -$62.4K ﹤0.01% 1253
2017
Q2
$264K Sell
5,138
-1,502
-23% -$65.2K ﹤0.01% 1230
2017
Q1
$286K Sell
6,640
-2,626
-28% -$113K ﹤0.01% 1263
2016
Q4
$349K Buy
9,266
+3,571
+63% +$133K ﹤0.01% 1269
2016
Q3
$233K Sell
5,695
-1,360
-19% -$53.8K ﹤0.01% 1277
2016
Q2
$213K Buy
7,055
+108
+2% +$3.36K ﹤0.01% 1385
2016
Q1
$230K Sell
6,947
-1,315
-16% -$41.3K ﹤0.01% 1340
2015
Q4
$312K Buy
+8,262
New +$278K ﹤0.01% 1275
2015
Q3
Sell
-7,162
Closed -$222K 1521
2015
Q2
$222K Sell
7,162
-3,545
-33% -$104K ﹤0.01% 1459
2015
Q1
$357K Sell
10,707
-1,194
-10% -$40.3K ﹤0.01% 1365
2014
Q4
$548K Sell
11,901
-10,110
-46% -$432K 0.01% 1146
2014
Q3
$811K Sell
22,011
-4,995
-18% -$182K 0.01% 1148
2014
Q2
$1.07M Sell
27,006
-27,106
-50% -$1.04M 0.01% 1124
2014
Q1
$2.57M Buy
+54,112
New +$2.39M 0.03% 601
2013
Q4
Sell
-33,755
Closed -$1.22M 1732
2013
Q3
$1.22M Sell
33,755
-239
-0.7% -$8.02K 0.03% 724
2013
Q2
$1.07M Buy
+33,994
New +$963K 0.02% 808

Other funds holding PODD

ProShare Advisors's PODD Position: Q1 2026 in Review

ProShare Advisors reduced its Insulet (PODD) stake by 11% in Q1 2026, selling an estimated $513K and leaving 15,951 shares worth $3.35M. The position accounts for 0.01% of the portfolio, ranked #626.

ProShare Advisors first reported a position in PODD in Q2 2013 and has held it in 46 quarters since. The position peaked at $5.11M in Q4 2025. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • ProShare Advisors held 15,951 shares of Insulet worth $3.35M as of Q1 2026.
  • ProShare Advisors sold 2,042 Insulet shares in Q1 2026, an estimated $513K.
  • Insulet made up 0.01% of ProShare Advisors's portfolio in Q1 2026, its #626 holding.
  • ProShare Advisors first reported a position in Insulet in Q2 2013 and has held it in 46 quarters since.
  • ProShare Advisors's Insulet position peaked at $5.11M in Q4 2025.
  • 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.